Literature DB >> 3919452

Identification of two complementation groups in Fanconi anemia.

G Duckworth-Rysiecki, K Cornish, C A Clarke, M Buchwald.   

Abstract

Considerable variation can be observed in the clinical presentation of Fanconi anemia (FA) patients and in the degree of sensitivity of their cells to DNA damaging agents. We have examined the hypothesis that genetic heterogeneity underlies this variation by testing for complementation in somatic cell hybrids constructed from FA cells. Hybrids were formed by fusing lymphoblastoid cell lines derived from four different FA patients. Complementation of the cellular defects in FA was tested by examining sensitivity to growth inhibition by mitomycin C(MMC), spontaneous chromosome breakage, and MMC-induced chromosome breakage in the hybrid cells. These studies revealed the presence of at least two complementation groups, suggesting that there may be two or more different FA genes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919452     DOI: 10.1007/bf01534732

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  25 in total

1.  Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.

Authors:  H Joenje; M Levitus; Q Waisfisz; A D'Andrea; I Garcia-Higuera; T Pearson; C G van Berkel; M A Rooimans; N Morgan; C G Mathew; F Arwert
Journal:  Am J Hum Genet       Date:  2000-08-08       Impact factor: 11.025

2.  Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus.

Authors:  D Papadopoulo; C Guillouf; H Mohrenweiser; E Moustacchi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA. Phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents.

Authors:  C Diatloff-Zito; F Rosselli; J Heddle; E Moustacchi
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

Review 4.  Human DNA repair defects.

Authors:  C F Arlett
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

5.  Abnormal response to DNA crosslinking agents of Fanconi anemia fibroblasts can be corrected by transfection with normal human DNA.

Authors:  C Diatloff-Zito; D Papadopoulo; D Averbeck; E Moustacchi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6.

Authors:  F Rosselli; J Sanceau; J Wietzerbin; E Moustacchi
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

7.  MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.

Authors:  Y Li; H Youssoufian
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

8.  Fanconi's anaemia: correlation of genetic complementation group with psoralen/UVA response.

Authors:  M Digweed; S Zakrzewski-Lüdcke; K Sperling
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

9.  Molecular cloning of SNM1, a yeast gene responsible for a specific step in the repair of cross-linked DNA.

Authors:  E Haase; D Riehl; M Mack; M Brendel
Journal:  Mol Gen Genet       Date:  1989-07

10.  Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.

Authors:  Igor Landais; Sanne Hiddingh; Matthew McCarroll; Chao Yang; Aiming Sun; Mitchell S Turker; James P Snyder; Maureen E Hoatlin
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.